| Product Code: ETC9970970 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Multiplex Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Multiplex Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Multiplex Testing Market - Industry Life Cycle |
3.4 United States (US) Multiplex Testing Market - Porter's Five Forces |
3.5 United States (US) Multiplex Testing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Multiplex Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) Multiplex Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) Multiplex Testing Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 United States (US) Multiplex Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Technological advancements in multiplex testing leading to improved accuracy and efficiency |
4.2.3 Growing prevalence of chronic diseases requiring early and accurate diagnosis |
4.3 Market Restraints |
4.3.1 High cost associated with multiplex testing procedures |
4.3.2 Lack of reimbursement policies for multiplex testing in certain regions |
4.3.3 Regulatory challenges and approval processes for introducing new multiplex testing products |
5 United States (US) Multiplex Testing Market Trends |
6 United States (US) Multiplex Testing Market, By Types |
6.1 United States (US) Multiplex Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Multiplex Testing Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Multiplex Testing Market Revenues & Volume, By Reagents, 2021- 2031F |
6.1.4 United States (US) Multiplex Testing Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 United States (US) Multiplex Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Multiplex Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Multiplex Testing Market Revenues & Volume, By xMAP (Multi-Analyte Profiling), 2021- 2031F |
6.2.3 United States (US) Multiplex Testing Market Revenues & Volume, By RT-PCR (Real Time Polymerase Chain Reaction), 2021- 2031F |
6.2.4 United States (US) Multiplex Testing Market Revenues & Volume, By ELISA (Enzyme-Linked Immunosorbent Assay), 2021- 2031F |
6.2.5 United States (US) Multiplex Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Multiplex Testing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Multiplex Testing Market Revenues & Volume, By Influenza A, 2021- 2031F |
6.3.3 United States (US) Multiplex Testing Market Revenues & Volume, By Influenza B, 2021- 2031F |
6.3.4 United States (US) Multiplex Testing Market Revenues & Volume, By Parainfluenza Viruses, 2021- 2031F |
6.3.5 United States (US) Multiplex Testing Market Revenues & Volume, By Adenovirus, 2021- 2031F |
6.3.6 United States (US) Multiplex Testing Market Revenues & Volume, By Respiratory Syncytial Virus (RSV), 2021- 2031F |
6.3.7 United States (US) Multiplex Testing Market Revenues & Volume, By Coronaviruses, 2021- 2031F |
6.3.8 United States (US) Multiplex Testing Market Revenues & Volume, By Group Rhino- and Enteroviruses, 2021- 2031F |
6.3.9 United States (US) Multiplex Testing Market Revenues & Volume, By Group Rhino- and Enteroviruses, 2021- 2031F |
6.4 United States (US) Multiplex Testing Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Multiplex Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Multiplex Testing Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.4.4 United States (US) Multiplex Testing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.4.5 United States (US) Multiplex Testing Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.6 United States (US) Multiplex Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Multiplex Testing Market Import-Export Trade Statistics |
7.1 United States (US) Multiplex Testing Market Export to Major Countries |
7.2 United States (US) Multiplex Testing Market Imports from Major Countries |
8 United States (US) Multiplex Testing Market Key Performance Indicators |
8.1 Adoption rate of multiplex testing technologies in clinical settings |
8.2 Number of research studies and publications utilizing multiplex testing |
8.3 Investment and funding trends in the multiplex testing market |
8.4 Rate of development and commercialization of new multiplex testing assays |
8.5 Level of collaboration and partnerships between key industry players in the multiplex testing market |
9 United States (US) Multiplex Testing Market - Opportunity Assessment |
9.1 United States (US) Multiplex Testing Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Multiplex Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) Multiplex Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) Multiplex Testing Market Opportunity Assessment, By End user, 2021 & 2031F |
10 United States (US) Multiplex Testing Market - Competitive Landscape |
10.1 United States (US) Multiplex Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Multiplex Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here